Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAPT duration based on bleeding risk in coronary artery disease
NCT05631769Phase 4Active, not recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Jul 2020
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin in coronary artery disease (CAD), acute myocardial infarction (AMI), stable angina, sponsored by Seoul National University Hospital. Started Jul 2020; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
coronary artery disease (CAD)acute myocardial infarction (AMI)stable angina
Beyond the preview
Go deeper on NCT05631769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05631769.